Data from: Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

Hagiwara A, Tanaka N, Uemura T, Wataru M, Kimura A

Date Published: November 23, 2016

DOI: http://dx.doi.org/10.5061/dryad.2n6v4

 

Files in this package

Content in the Dryad Digital Repository is offered "as is." By downloading files, you agree to the Dryad Terms of Service. To the extent possible under law, the authors have waived all copyright and related or neighboring rights to this data. CC0 (opens a new window) Open Data (opens a new window)

Title rhTM open data
Downloaded 59 times
Description rhTM, recombinant human thrombomodulin; FDP, fibrin/fibrinogen degradation products; FDP0, FDP value ar day 0; delta, Relative change rate from baseline = ([measurement day value − day 0 value]/day 0 value); delta FDP1, ([FDP value at day 1− day 0 value]/day 0 value); PLT, platelet; Fib, fibrinogen; PT, PTINR, prothrombin time ratio, –international normalized ratio; PTperc, PT percentage; APTT, partial thromboplastin time; ATIII, antithrombin III; TM, thrombomodulin value; SIRS, Systemic inflammatory response syndrome; SOFA, sequential organ failure assessment score; SOFA PF, SOFA respiratory score; SOFA PL, SOFA coagulation score; SOFA bil, SOFA hepatic dysfunction score; SOFA CV, SOFA cardiovascular system score; SOFA GCS, SOFA Glasgow Come Scale score; SOFA Cr, SOFA renal dysfunction score.
Download coagulation_data_clean_R Open data.xlsx (138.7 Kb)
Details View File Details

When using this data, please cite the original publication:

Hagiwara A, Tanaka N, Uemura T, Matsuda W, Kimura A (2016) Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial. BMJ Open 6(12): e012850. http://dx.doi.org/10.1136/bmjopen-2016-012850

Additionally, please cite the Dryad data package:

Hagiwara A, Tanaka N, Uemura T, Wataru M, Kimura A (2016) Data from: Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial. Dryad Digital Repository. http://dx.doi.org/10.5061/dryad.2n6v4
Cite | Share
Download the data package citation in the following formats:
   RIS (compatible with EndNote, Reference Manager, ProCite, RefWorks)
   BibTex (compatible with BibDesk, LaTeX)

Search for data

Be part of Dryad

We encourage organizations to: